Efficient DNA electrotransfer into muscles can be achieved by combining two types of electronic pulses sequentially: short high-voltage (HV) pulse for the cell electropermeabilization and long low-voltage (LV) pulse for the DNA electrophoresis into cells. However, the voltages currently applied can still induce histological and functional damages to tissues. Pluronic L64 has been considered as a molecule possessing cell membrane-disturbing ability. For these reasons, we hope that L64 can be used as a substitute for the HV pulse in cell membrane permeabilization, and a safe LV pulse may still keep the ability to drive plasmid DNA across the permeabilized membrane. In this work, we optimized the electrotransfer parameters to establish a safe and efficient procedure using a clinically applied instrument, and found out that the critical condition for a successful combination of electrotransfer with L64 was that the injection of plasmid/L64 mixture should be applied 1 h before the electrotransfer. In addition, we revealed that the combined procedure could not efficiently transfer plasmid into solid tumor because the uncompressed plasmid may rapidly permeate the leaky tumor vessels and flow away. Altogether, the results demonstrate that the combined procedure has the potential for plasmid-based gene therapy through safe and efficient local gene delivery into skeletal muscles.
INTRODUCTION
Delivery of genes into skeletal muscles is considered to be simple and easy to apply. 1 For many years, scientists have been trying to improve the delivery efficiency and expression level of transgenes in order to establish practicable gene therapy procedures. Viral vectors have the highest level of gene transfer and expression, but their potential threats to human beings limit their clinical applications. 2, 3 For this reason, non-viral gene delivery materials and electrotransfer, both widely used, have attracted much attention in local gene delivery. 4, 5 The use of an electric field to alter cell membrane permeability has been known since the 1960s. 6 The first in vitro and in vivo attempts to utilize electrotransfer for gene delivery were demonstrated in 1982 and 1991, respectively. 7, 8 Compared with plasmid DNA (pDNA) injection alone, addition of electric pulse drastically increases transgene expression and reduces the inter-individual heterogeneity on gene expression. 9 The mechanism of electrotransfer has been considered as the generation of transient pores in cell membranes by the electric pulse, followed by an electrophoretic DNA movement into cells. 10 Accordingly, a modified procedure has been established by combining two types of electronic pulses: short high-voltage (HV) pulse for the cell permeabilization and long low-voltage (LV) for the DNA electrophoresis into cells. 11, 12 However, the commonly used high and low voltages in the HV-LV model still exhibit potential safety risk to the living body as well as histological damage and functional deterioration on local tissue. 13, 14 Reducing the electric voltage can alleviate side effects but inevitably decreases the gene transfer efficiency. 15, 16 Therefore, in this work we wanted to both identify an alternative method to replace the HV for cell membrane permeabilization and optimize the LV procedure for safe and effective gene transfer.
Non-viral gene delivery materials have been developed for many years due to their good biocompatibility, high efficiency and controllable synthesis. 17 Many materials, such as cationic lipids and polymers, have been successfully applied in cultured cell transfection but have failed in local gene transfer into muscles. 18 More recently, amphiphilic triblock copolymers of poly(ethylene oxide) and poly(propylene oxide) ((PEO)x-(PPO)y-(PEO)x), called Pluronic or poloxamer, have shown promise in the field of gene delivery. 19, 20 Pluronic L64 ((PEO) 30 -(PPO) 13 -(PEO) 30 ) has been one of the most effective carriers for transgene expression in mice skeletal and cardiac muscles. 21 Its amphiphilic triblock structure shares similarity with the phospholipid bilayer of the cell membrane. It has been shown that L64 could reduce the microviscosity of a model membrane of liposome 22 and help Evans blue dye to penetrate into muscle fibers. 23 As a result, L64 has been considered as a molecule that could disturb the cell membrane and increase its permeability. We are interested to know whether L64 can be used as a potential substitution of the HV for electropermeabilization, thus helping in reducing the undesired side effects.
In this study, we have tried to establish a combined physicochemical procedure with good biocompatibility and outstanding efficiency for in situ gene delivery. A successful outcome could provide another potential approach for pDNA-based gene therapy.
RESULTS
Electric currents influenced by the pulse frequency and stimulation intensity The intensities of electric currents between two electrodes of the SDZ-V Nerve and Muscle Stimulator (Hwato, Suzhou Medical Appliance Factory, China) were detected under different electric pulse frequencies and stimulation intensities. The results showed that the electric current intensities were positively correlated with the stimulation intensities and pulse frequencies: at fixed frequency, the higher stimulation intensities generated stronger electric currents; at fixed stimulation intensity, the current intensities increased with the acceleration of pulse frequencies ( Figure 1) . As the electric current intensity is one of the critical factors influencing the in vivo electrotransfer efficiency, the results indicate that the electrotransfer efficiency can be improved by increasing the electric pulse frequency and stimulation intensity.
Optimization of the electrotransfer procedure for local gene delivery Two variable and critical factors, electric stimulation duration and pulse frequency, were optimized in order to get the best results of local gene expression in mice tibialis anterior (TA) muscles. Qualitative evaluations through the visualized β-galactosidase expression were firstly carried out. The results showed that 3 min was the optimal time duration (Figure 2a ), while 5, 7 and 10 Hz all had strong transgene expression (Figure 2c ). Subsequent analysis of the luciferase expression quantitatively confirmed that 3 min ( Figure 2b ) and 5 Hz (Figure 2d) were the most suitable parameters, respectively. When the pulse frequency was increased to ⩾ 20 Hz, mice were uncomfortable and struggled drastically. Consequently, the parameters of 3 min and 5 Hz were considered to be suitable for electrotransfer.
Pre-injection of pDNA/L64 mixture followed by electrotransfer greatly promotes transgene expression in muscles Pluronic L64 has been reported to be one of the most powerful synthetic vectors capable of improving intramuscular gene delivery. After the optimization of the electrotransfer parameters, we tried to combine L64 with this method to establish a safer and more powerful procedure for local gene delivery. We observed that when the electrotransfer was applied immediately after the injection of pDNA/L64 mixture, the transgene expressions were not increased (Figures 3a and b, P/L/E(0h) vs P/E and P/L). However, if the electrotransfer was applied 1 h after the pDNA/L64 injection, the qualitative β-galactosidase expression was significantly increased (Figures 3a, P/L/E(1h) vs other groups); the luciferase expression in P/L/E(1h) treatment was quantitatively increased to~11 times (Figure 3b , P/L/E(1h) vs P/E, P/L and P/L/E (0h)), and even~80 times when compared with pDNA injection alone (Figures 3b, P/L/E(1h) vs P). To detect the intensity and duration of transgene expression in living animals, the plasmid pSC-E2 was constructed, which utilizes an enhanced hybrid promoter to drive the expression of the far-red fluorescent protein E2-Crimson for in vivo imaging. After a single injection and treatment, animals in the four groups showed different levels of visible fluorescent protein expression and the P/L/E group had the best performance. Meanwhile, the expression of fluorescent protein has sustained for at least 4 weeks without any attenuation (Figure 3c ).
Local delivery of pSC-GH plasmid into skeletal muscle enhances the concentration of mouse growth hormone in circulation After we have demonstrated that the P/L/E treatment has the most pronounced positive effect on reporter gene expression, such as β-galactosidase, luciferase and E2-Crimson, we would like to know if a functional gene expression could be increased to such a high level that the biological effect can be easily detected or observed. As shown in Figure 4 , the concentration of circulatory mouse growth hormone (GH) in the P/L/E treatment was significantly increased when compared with others, and was 2.5 times that in the control group.
In vivo biocompatibility evaluations of different gene delivery methods The in vivo biocompatibility of the various gene delivery methods, especially those based on the application of electrotransfer, should be evaluated in order to account for the potential damage on tissues. After being treated with optimized electrotransfer, mice did not show any function restriction on their hindlimbs and moved normally. Hematoxylin and eosin staining was utilized to assess the general morphology of the TA muscle and to visualize if there were any pathological changes in the injected sites. All the four treatments did not induce any morphological change in the muscles. There was no infiltration of inflammatory cells and centrally nucleated muscle fiber (a marker of myofiber regeneration), and no area of necrosis was observed either (Figure 5a ). These findings indicate that the optimized electrotransfer and L64-mediated methods are safe for in vivo applications. However, a large area of necrotic muscle fibers appeared as soon as the frequency was increased to ⩾ 50 Hz (Figure 5b ).
The muscle-based local gene delivery methods do not work in tumors Superficial solid tumors are available for injection and electric pulse; thereby we were interested in investigating if the reporter genes can be effectively transferred and expressed in the tumors using the aforementioned methods. At first, the results showed, surprisingly, consistent LacZ staining in different groups ( Figure 6a ). Our continued efforts were still differing from our expectations as the plasmid pSC-E2 showed no fluorescent signal after being administered into tumors using all the four methods (data not shown). A detailed quantitative analysis confirmed that the four methods had identical performance on luciferase gene expression; it also indicated that transgene expression in tumor was much lower than that in muscle ( Figure 6b ). In order to unravel the reason for this phenomenon, the labeled plasmid was injected into tumors and muscles, and fluorescent signals were detected at different time points. It turned out that, as soon as they were injected into tumors, the plasmids diffused rapidly and as a result the fluorescent signals attenuated within 30 min. When injected into muscles, the labeled plasmids stayed along the needle trace and the fluorescent signal kept the same intensity for at least 2 h (Figure 6c ). Correlation between pulse frequency, stimulation intensity and output current at fixed resistance. Measurement of the output was done according to the standard YY0780-2010 promulgated by the State Food and Drug Administration (SFDA). Briefly, the output waveform and voltage were measured using a parallel oscilloscope connected with a load resistance of 250 Ohm, which was placed between the electrodes, and the electric currents (r.m.s., root mean square) were calculated according to the formula: I = U/R (I: output current; U: voltage; R: resistance). The output currents (r.m.s.) were detected at different stimulation intensities from 1 to 65 levels and different pulse frequencies from 5 to 100 Hz.
DISCUSSION
The critical factors influencing in vivo electrotransfer efficiency are electric field strength, current intensity, pulse duration and wave pattern. [24] [25] [26] In this study, a clinically used instrument, able to generate a continuous square-wave pulse with 9-V direct current, was applied for electrotransfer. The distance between two electrode plates was~0.4 cm, which is of the order of the thickness of mouse TA muscle. Therefore, the final electric field strength was about 20 V cm − 1 , which was the lowest one that has been used in electrotransfer by far. 27 The voltage and electric field strength used here were considered safe for human applications. The electric current intensities were increased with the stimulation intensities, and pulse frequencies, namely, the higher intensities and faster frequencies, provided stronger electric currents ( Figure 1 ). In clinical application for traditional nerve or muscle stimulation, the required intensity was determined by the patient's feeling and reaction. In this study, third-level intensity was chosen based on both the adaptability and reaction of the mice. No mouse showed discomfort under this stimulus strength. The frequency and total duration time of the electric pulse were further optimized, resulting in a safe and efficient electrotransfer procedure with the following parameters: 20 V cm − 1 of electric field strength, 5 Hz of pulse frequency, 3 rd level of stimulation intensity and 3 min of total electric stimulation duration. The total pulse number reached 900 and the pulse duration, given that the single pulse width was 0.2 ms, was equal to 180 ms. The optimized procedure provided strong reporter gene expression and minimized side effects in mice muscles, as evident from the qualitative assay of β-galactosidase, quantitative assay of luciferase expression and pathological analysis of muscular sections. For bigger living bodies such as rats or even humans, the parameters can be modified with regard to increased level of stimulation intensity, higher pulse frequency and longer duration, in order to get satisfactory electrotransfer effect.
Previously, scientists have failed to increase transgene expression owing to the application of the electric pulse immediately after intramuscular injection of pDNA/L64 mixture. 28 We found out that the key factor required for a successful combination of electrotransfer with L64 was a certain period of time between the pDNA/L64 injection and the following electrotransfer. A possible explanation might be that the L64-induced permeabilization is a slow kinetic process. 29 Prior to the application of electric pulse, Pluronic L64 would benefit from the retention time for sufficient interaction with the cell membrane. The permeabilized membrane is more ready for the migration of pDNA driven by the extremely low voltage.
In practice, the muscle can serve as a factory for therapeutic or functional protein synthesis and secretion so that the biological effects of the protein can be achieved. 30 When the plasmid pSC-GH was injected into the TA muscle, the serous GH in P/L/E group was greatly improved (Figure 4) . However, we did not see the biological effects of GH on mouse growth, as the mouse growth rate between different groups had no statistical difference (data not shown). This may be due to two reasons. First, the muscleexpressed GH is not strong enough to significantly accelerate mouse growth. Second, the sophisticated regulatory mechanism of GH may influence the final effects of circulatory GH. Under normal physiological conditions, GH is synthesized and stored in the somatotropic cells within the lateral wings of the anterior pituitary gland, and released into the bloodstream in a pulsatile manner regulated by both the hypothalamic GH-releasing hormone and GH-inhibiting hormone. The GH-inhibiting hormone and the circulating concentration of GH can inhibit the secretion of GH from the pituitary gland. This means that the muscleexpressed exogenous GH will also act as a negative feedback on the secretion of endogenic GH. The concentration of exogenous GH should be high enough to compensate the reduced endogenic GH secretion as well as to produce physiological effects on mice growth. Considering that only a single injection of 10 μg pSC-GH was applied, it was envisaged that repeated administration of higher dose of the plasmid may result in better performance on mouse growth.
In tumor cells, many biological events including gene expression are usually more active than those in terminally differentiated muscle cells. This makes tumors attractive targets for exogenous gene delivery and expression. 31 As the P/L/E operation can be easily applied to superficial solid tumors, it was believed that it may offer higher transgene expression in tumors. The results, however, were completely different from the expectations. Reporter gene expression in tumors was drastically reduced when compared with that in muscle (Figure 6b ). In tumors, the newly formed blood vessels are usually abnormal in form and architecture, generating leaky vessels for easy penetration of Safe and efficient local gene delivery into skeletal muscle S Liu et al small molecules. The typical case is the enhanced permeability and retention effect, by which certain sizes of molecules tend to permeate the leaky vessels and accumulate in the extravascular matrix of tumor tissue. 32 Therefore, it was thought that the unpacked DNA and L64 molecules were so small that they could easily and reversely permeate into the blood flow through the leaky vessels and were rapidly taken away. As observed, the labeled pDNA with blue color immediately appeared in the superficial blood vessels of tumors after the injection (data not shown). The in vivo imaging system confirmed that the signals of labeled pDNA in tumors attenuated rapidly and disappeared in 1.5-2 h, whereas the signals in TA muscles did not show any attenuation in 2 h (Figure 6c ) and were still detectable 16 h later (data not shown). The results indicated that the techniques and mechanisms for muscle-and tumor-based gene delivery were quite different from each other. We consider that, for successful delivery and expression in tumors, pDNA should be packed into a certain size and architecture using some kinds of biomaterials, or locally restricted in tumors by specific types of hydrogels, so that it might be prevented from flowing away Figure 3 . Comparison of the efficiencies of different methods for in vivo gene delivery. Detections were made at day 3 (a, b) or at different times (c) after local gene delivery into mice TA muscles using different approaches: P, pDNA injection alone; P/E, pDNA injection with immediate electrotransfer; P/L, injection of pDNA/L64 mixture; P/L/E(0h), electrotransfer was applied immediately after pDNA/L64 injection; P/L/E(1 h) and P/L/E, electrotransfer was applied 1 h after pDNA/L64 injection; Control, injection of saline. (a) Representative pictures in each group are displayed for qualitative evaluation of β-galactosidase gene expression. n = 6 per group. (b) Quantitative analysis of transgene expression using luciferase activity assay. Data were presented as mean ± s.d. n = 10 per group. (c) Intensity and duration of the far-red fluorescent protein expression in mice TA muscles. Animals were imaged using an in vivo imaging system and two pictures from the right (R) and left (L) sides of one mouse are presented. n = 6 per group. through the circulation. Utilization of tumors as targets for expression of therapeutic molecules is still an attractive option, but more work needs to be done before this becomes a reality.
The local gene delivery approach established in this study avoided the side effects induced by traditional electrotransfer methods and greatly improved the level of exogenous gene expression. For human beings, the stimulation intensity, duration and pulse frequency can be increased to get efficient transgene expression. The results indicated that the combined physicochemical method has potential for practical applications in pDNAbased gene therapy.
MATERIALS AND METHODS

Plasmid construction and preparation
It has been reported that the simian virus 40 enhancer (SV40E) provided higher and longer-lasting transgene expression driven by the cytomegalovirus (CMV) promoter in mouse skeletal muscle. 33 SV40E was inserted at the upstream of the CMV promoter in the plasmid pcDNA3.1(+) to construct the pSV40E/CMV (pSC), which allowed higher expression of cloned genes. SV40E and firefly Luciferase gene were amplified from the plasmid pGL3-control (Promega, Madison, WI, USA); β-D-galactosidase (LacZ) was from pUB6/V5-His/LacZ (Invitrogen, Carlsbad, CA, USA) and E2-Crimson (E2) from pE2-Crimson (Clontech, TaKaRa Biotechnology (Da Lian) Co., Ltd, Dalian, China). The mouse growth hormone gene (GenBank version: NM_008117.3) was amplified using the template cDNA, which was reversely transcripted from the pituitary gland messenger RNA of a newborn BALB/c mouse. Other information for the plasmids is shown in Table 1 . Primer synthesis and DNA sequencing were performed by Invitrogen Shanghai (Shanghai, China). All the constructed plasmids were identified by PCR amplification, restriction enzyme digestion and DNA sequencing analysis. The plasmids were amplified in Escherichia coli DH5α and then extracted using the Endo-Free Plasmid Mega Kits (Qiagen, Dusseldorf, Germany).
Preparation of experimental animals
Animal care and experimental operation were performed according to the national and local guidelines of animal experimentation. Eight-week-old male BALB/c mice with 20-22 g weight (bought from the West China Animal Culture Center of Sichuan University, Chengdu, China) were used for in vivo gene delivery and expression assays. To establish the tumorbearing mouse model, both dorsal parts of a mouse were shaved and subcutaneously inoculated with 5 × 10 5 per site of 4T1 mouse mammary gland tumor cells in 30 μl phosphate-buffered saline (PBS) buffer.
Local gene delivery
Pluronic L64 (L64; Sigma-Aldrich, St Louis, MO, USA) solution was diluted to 0.2% (w/v) using saline, gently and thoroughly mixed with equal volume of pDNA, and kept for 5 min at room temperature before injection. Both Figure 4 . Concentration of growth hormone in circulation. Ten micrograms of pSC-GH plasmid was injected into one side of the TA muscle in a 6-week-old mouse. Concentration of the GH in serum was tested 3 days later using a mouse GH ELISA kit. n = 6 per group. P o0.05, *: vs saline group (Control), #: vs pSC-GH (P) and Control, +: vs other groups. Safe and efficient local gene delivery into skeletal muscle S Liu et al mouse hindlimbs were shaved and depilated with hair removal cream for intramuscular injection. Tumors with regular shape and similar size (0.5-0.8 cm in diameter) were picked out for intratumoral injection. Each side of the TA muscle in a mouse or each tumor was injected with 30 μl saline containing 10 μg of pDNA or pDNA/L64 (0.1%) mixture using a 29-gauge BD Ultra-Fine insulin syringe (BD, Franklin Lakes, NJ, USA). The injected site was in the middle of a TA muscle or tumor and the injection time was 2-3 s.
Electrotransfer
A clinically applied SDZ-V Nerve and Muscle Stimulator was used for electrotransfer, which generates 9-V direct current pulses with continuous square waves. Transcutaneous electric pulses were applied at a defined time after injection (30 s or 1 h, depending on the experiment). The two electrode plates were placed at each side of a TA muscle or tumor to ensure that the injection point was in the middle of the applied electric field. Electrical contact between the skin and the plate was guaranteed by completely removing the hair and wetting the plates and skin. The electric current generated by the instrument is influenced by two variable factors: the stimulation intensity and the pulse frequency. The stimulation intensity is graded into 65 levels. The third level was found to be suitable in this study because the stronger stimulation induced uncomfortable shake and struggle of the mice. The pulse frequency is adjustable within 1-100 Hz and the pulse width is fixed to 0.2 ms. Therefore, the pulse frequency and stimulation duration were adjusted in order to get an optimized result with regard to the transgene expression and biocompatibility.
In vivo activity assays of reporter genes Mice were killed and samples were separated 3 days after treatments. For β-galactosidase activity assay, samples were soaked in the freshly prepared fixative (2% paraformaldehyde and 0.2% glutaraldehyde in PBS) for 1 h on ice. Fixed samples were rinsed 3 times with PBS at room temperature, and incubated in X-Gal staining solution (5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 2 mM MgCl 2, 0.01% deoxycholate, 0.02% NP-40, 1 mg ml − 1 X-Gal in PBS) for 6 h at 37°C. Soon afterwards, samples were fixed in 4% paraformaldehyde and photographed with a digital camera. For luciferase activity assay, the sample was homogenized on ice with a T10 ULTRA-TURRAX homogenizer (IKA-werke, Baden Wuerttemberg, Germany) in 1 ml of reporter lysis buffer (Promega) for a TA muscle or a suitable volume of the buffer according to the weight of a tumor. A portion of the homogenized sample was subjected to one cycle of lysis involving freezing in liquid nitrogen and thawing in 37°C water bath. The tissue lysate was centrifuged at 12 000 g for 5 min at 4°C. Hundred microliters of luciferase substrate (Promega) was added to 20 μl of lysate supernatant and the luciferase activity was detected by measuring the light emission for 10 s in a Varioskan Flash spectral scanning multimode reader (Thermo Fisher, Waltham, MA, USA). Relative light unit was normalized to the total protein concentration of the lysate supernatant, which was measured with a BCA Protein Assay Kit (Pierce, Rockford, IL, USA).
DNA labeling
The plasmid pEGFP-C1 was stained using the dimeric cyanine nucleic acid dye TOTO-3 (Invitrogen). To get a ratio of 10:1, DNA base pairs to dye molecules, 10 μg of pDNA in 15 μl PBS buffer was added to 15 μl of 0.1 mM TOTO-3 solution (prepared by 1:10 dilution of the 1-mM stock solution with PBS buffer) and mixed gently and thoroughly. The mixture was kept in a dark place for 60 min at room temperature. The pDNA was precipitated by adding 1/10 volume of 3 mol l − 1 sodium acetate (pH 5.3) and 2 volumes of 100% ethanol, placed on ice for 20 min, and centrifuged at 13 000 × g for 10 min. The precipitated pDNA was washed twice with 75% ethanol, redissolved in ddH 2 O to get a final concentration of 1 μg μl − 1 and stored at 4°C.
In vivo imaging of expressed fluorescent protein or labeled pDNA
The imaging sites (TA muscles and tumors) of mice were completely depilated before imaging. Animals were anesthetized with 300 mg kg − 1 chloral hydrate and imaged by the in vivo imaging system (CRI Maestro, Boston, MA, USA). The locally expressed E2-Crimsom far-red fluorescent protein was detected on days 7, 14, 21 and 28 after injection, respectively. To track the pDNA in situ, 2 μg of TOTO3-labeled pDNA in 30 μl PBS was injected into the TA muscle or tumor, and detected at different time points. Images were excited by the yellow light and scanned ranging from 600 to 700 nm at room temperature to get the emitting light.
Hematoxylin and eosin staining TA muscles were fixed in 4% neutral buffered formaldehyde, dehydrated with different concentrations of ethanol and embedded in paraffin. Specimens were sliced in both cross-sections and longitudinal sections with 10 μm thickness. Sections were immersed in hematoxylin for 3 min and then dipped in eosin, dried with a suction pipette and mounted in mineral oil under a coverslip to prevent dehydration and preserve morphology and staining. Microscopic analysis and histopathological changes were observed by using an IX71 microscope (Olympus, Tokyo, Japan).
Statistical analysis
Data were expressed as the mean ± s.d. Comparisons among groups were made using Student's t-test to assume two-tailed distribution and unequal variances. A value of Po 0.05 was considered significant difference, and Po0.01 as highly significant difference.
